Clinical trials · District of Columbia
Pulmonary Embolism clinical trials in District of Columbia
We’re tracking 3 recruiting pulmonary embolism studies with a site in District of Columbia — including Phase 3 studies, each written for real people, not researchers.
Recruiting studies in District of Columbia
- NCT06041594Recruiting
Treating pulmonary embolism with the Laguna thrombectomy system
This trial tests a device (Laguna Thrombectomy System) to remove blood clots in the lungs. It may help people with a recent pulmonary embolism who are stable enough to undergo a minimally invasive procedure.
Washington D.C., District of ColumbiaAges 18–85 - NCT04798261Recruiting
Long-term follow-up after clot removal for pulmonary embolism
This study tracks how patients do long-term after having a clot in the lung treated with a device called the Indigo Aspiration System. It aims to better understand safety and outcomes over time.
Washington D.C., District of ColumbiaAges 18 years+ - NCT05591118RecruitingPhase 3
Catheter treatment to remove blood clots in the lungs
This Phase 3 trial tests a catheter-based procedure to remove a lung blood clot (pulmonary embolism) and reduce strain on the heart. It may help people who have specific CT scan signs of right-heart strain.
Washington D.C., District of ColumbiaAges 18 years+
Pulmonary Embolism trials by city in District of Columbia
Where these studies are running in District of Columbia
Institutions with a site for the recruiting pulmonary embolism studies listed above.
- George Washington University Hospital
- MedStar Health
- MedStar Washington Hospital Center
What taking part in a pulmonary embolism study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Pulmonary Embolism trials in other states
Common questions
- Are there pulmonary embolism clinical trials in District of Columbia?
- Yes. We're currently tracking 3 recruiting pulmonary embolism studies with a site in District of Columbia, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a pulmonary embolism study in District of Columbia?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in District of Columbia to take part?
- Not necessarily. These studies have a site in District of Columbia, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a pulmonary embolism trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New pulmonary embolism studies open in District of Columbia regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.